Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12610000259044
Ethics application status
Approved
Date submitted
29/03/2010
Date registered
30/03/2010
Date last updated
25/11/2021
Date data sharing statement initially provided
25/11/2021
Type of registration
Prospectively registered
Titles & IDs
Public title
The effect of sevoflurane on the corrected interval between the Q wave and T wave of the electrocardiogram (QTc) in patients with diabetes mellitus.
Query!
Scientific title
The effect of sevoflurane on the corrected QT interval (QTc), QTc dispersion, the interval between peak to end of T wave (Tp-e) and Tp-e/QTc ratio in diabetic and non diabetic women undergoing elective non-laparoscopic surgery requiring general anaesthesia with endotracheal intubation
Query!
Secondary ID [1]
1555
0
nil
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Diabetes Mellitus
257044
0
Query!
Condition category
Condition code
Anaesthesiology
257205
257205
0
0
Query!
Anaesthetics
Query!
Metabolic and Endocrine
257206
257206
0
0
Query!
Diabetes
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
General anaesthesia with sevoflurane at 1.0 minimum alveolar concentration (MAC) administered through an endotracheal tube in to the patients lungs during the surgical period which is roughly two hours.
Query!
Intervention code [1]
256221
0
Early detection / Screening
Query!
Intervention code [2]
256226
0
Other interventions
Query!
Comparator / control treatment
Diabetic patients would be compared with a control group of non-diabetic patients. Both the groups would receive exactly the same treatment.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
258099
0
Difference in Tp-e interval between- the groups and within the groups
This outcome measure and all other outcome measures was assessed from the same recorded electrocardiogram strips.
Query!
Assessment method [1]
258099
0
Query!
Timepoint [1]
258099
0
After intubation , and at 5 min , 15 min , 30 min , 60 min after general anaesthesia.
Query!
Primary outcome [2]
301635
0
Difference in Tp-e/QTc ratio between- the groups and within the groups
This outcome measure and all other outcome measures was assessed from the same recorded electrocardiogram strips.
Query!
Assessment method [2]
301635
0
Query!
Timepoint [2]
301635
0
After intubation, 5min, 15 min, 30 min and 60 minutes into the anaesthetic, Same as all the other outcomes
Query!
Secondary outcome [1]
263701
0
Difference between the QTc interval between- the groups and within the groups
This outcome measure and all other outcome measures was assessed from the same recorded electrocardiogram strips.
Query!
Assessment method [1]
263701
0
Query!
Timepoint [1]
263701
0
after intubation , and at 5 min , 15 min , 30 min , 60 min after general anaesthesia
Query!
Secondary outcome [2]
333360
0
Difference between the QTc Dispersion between- the groups and within the groups
This outcome measure and all other outcome measures was assessed from the same recorded electrocardiogram strips.
Query!
Assessment method [2]
333360
0
Query!
Timepoint [2]
333360
0
After intubation, 5 min, 15 min, 30 min and 60 min into the study period
Query!
Eligibility
Key inclusion criteria
Women aged > 40 yr ASA I – III (American society of Anesthesiologists physical status) scheduled for elective non-laparoscopic surgical procedures lasting more than 60 min requiring general anaesthesia with endotracheal intubation would be recruited in this study. Medically managed (both oral hypoglycaemic agents and insulin) diabetic patients with the duration of the disease for atleast two years or those who have atleast one HbA1c (glycosylated haemoglobin) level more than 7% recorded prior to the presentation would be compared with a control group of non diabetic patients.
Query!
Minimum age
40
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Patients with a preoperative QTc interval greater than 440ms, having conduction defects and arrhythmias, taking medications affecting the QTc interval , suffering from ischemic heart disease as defined by previous history of angina, myocardial infarction or ischaemic cardiomyopathy, patients with congenital or acquired cardiac defects, preexisting electrolyte imbalances and thyroid and renal dysfunction as defined by the estimated glomerular filtration rate (eGFR) < 60 ml/min/ 1.73m 2 would be excluded. Diabetic patients on diet control and patients with known or suspected family history of malignant hyperthermia would also be excluded
Query!
Study design
Purpose of the study
Prevention
Query!
Allocation to intervention
Non-randomised trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Other
Query!
Other design features
Patients will be enrolled at the preadmission clinic as they present to the surgical procedures if they fulfill the inclusion criteria and if they are willing to participate. The assignment is based on which group they belong to. The investigator interpreting the outcomes would be blinded to the group assignment
Query!
Phase
Phase 4
Query!
Type of endpoint/s
Safety
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Date of first participant enrolment
Anticipated
1/06/2010
Query!
Actual
30/09/2010
Query!
Date of last participant enrolment
Anticipated
20/12/2014
Query!
Actual
25/11/2014
Query!
Date of last data collection
Anticipated
20/12/2014
Query!
Actual
25/11/2014
Query!
Sample size
Target
40
Query!
Accrual to date
Query!
Final
35
Query!
Recruitment in Australia
Recruitment state(s)
SA
Query!
Recruitment hospital [1]
6521
0
The Queen Elizabeth Hospital - Woodville
Query!
Recruitment postcode(s) [1]
14094
0
5011 - Woodville
Query!
Funding & Sponsors
Funding source category [1]
256722
0
Hospital
Query!
Name [1]
256722
0
The Queen Elizabeth Hospital
Query!
Address [1]
256722
0
The Queen Elizabeth Hospital
28 Woodville Road
Woodville, SA 5011
Query!
Country [1]
256722
0
Australia
Query!
Primary sponsor type
Hospital
Query!
Name
The Queen Elizabeth Hospital
Query!
Address
The Queen Elizabeth Hospital
28 Woodville Road
Woodville, SA 5011
Query!
Country
Australia
Query!
Secondary sponsor category [1]
256006
0
None
Query!
Name [1]
256006
0
Query!
Address [1]
256006
0
Query!
Country [1]
256006
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
258731
0
The Queen Elizabeth Hospital Ethics Committee
Query!
Ethics committee address [1]
258731
0
28 Woodville Road Woodville South Australia 5011
Query!
Ethics committee country [1]
258731
0
Australia
Query!
Date submitted for ethics approval [1]
258731
0
07/04/2010
Query!
Approval date [1]
258731
0
23/01/2014
Query!
Ethics approval number [1]
258731
0
Query!
Summary
Brief summary
Sevoflurane is one of the widely used anaesthetic vapours for general anaesthesia. This vapour is delivered to the patients lungs through a breathing tube. It is known to alter the electrical activity of the heart. This manifests as a prolonged QTc interval of the electrocardiogram (ECG). One of the potential dangers associated with this phenomenon is the occurrence of a dangerous irregular heart beat. However, it is a very rare condition. People with diabetes mellitus are more prone to have a prolonged QTc interval due to various reasons. It is not known whether the diabetic patients are at an increased risk of QTc prolongation compared with non diabetics on exposure to sevoflurane anaesthesia. This study tries to look at the impact of sevoflurane on the QTc interval in patients with diabetes mellitus. The primary outcome parameters of interest are the Tp-e interval and Tp-e / QTc ratio of the ECG, as these measures are sensitive in predicting dangerous arrhythmias. The secondary outcome measures of interest are Qtc and QTcd values of the ECG.
Query!
Trial website
Query!
Trial related presentations / publications
None, Trying to publish
Query!
Public notes
Query!
Contacts
Principal investigator
Name
30988
0
Dr Venkatesan Thiruvenkatarajan
Query!
Address
30988
0
Department of Anaesthesia, The Quen Elizabeth Hospital, Woodville, SA
Query!
Country
30988
0
Australia
Query!
Phone
30988
0
0061431819763
Query!
Fax
30988
0
Query!
Email
30988
0
[email protected]
Query!
Contact person for public queries
Name
14235
0
Venkatesan Thiruvenkatarajan
Query!
Address
14235
0
Department of Anaesthesia
The Queen Elizabeth Hospital
28 Woodville Road
Woodville
SA 5011
Query!
Country
14235
0
Australia
Query!
Phone
14235
0
+61 8 82226640
Query!
Fax
14235
0
+61 8 82227065
Query!
Email
14235
0
[email protected]
Query!
Contact person for scientific queries
Name
5163
0
Venkatesan Thiruvenkatarajan
Query!
Address
5163
0
Department of Anaesthesia
The Queen Elizabeth Hospital
28 Woodville Road
Woodville
SA 5011
Query!
Country
5163
0
Australia
Query!
Phone
5163
0
+61 8 82226640
Query!
Fax
5163
0
+61 8 82227065
Query!
Email
5163
0
[email protected]
Query!
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
Query!
No/undecided IPD sharing reason/comment
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF